Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.57
Peer-review started: July 23, 2015
First decision: October 13, 2015
Revised: November 13, 2015
Accepted: December 7, 2015
Article in press: December 8, 2015
Published online: February 8, 2016
Processing time: 192 Days and 13.7 Hours
Although the triad of bronchiectasis, sinusitis and situs inversus was first described by Kartagener in 1933, the clinical spectrum of primary ciliary dyskinesia is still under investigation. Heterotaxy defects as well as upper and lower respiratory tract symptoms are the main manifestations in childhood. It is now recognized that situs inversus is encountered in only half of patients. The first lower respiratory symptoms may be present from infancy as neonatal respiratory distress. The most common lower airway manifestations are chronic wet cough, recurrent pneumonia and therapy resistant wheezing. Patients are at risk of developing bronchiectasis which may even be the presenting finding due to delayed diagnosis. Upper respiratory tract infections such as nasal congestion, nasal drainage and recurrent sinusitis as well as otologic manifestations such as otitis media or otorrhea with conductive hearing loss are also often encountered. It seems that the type of ciliary ultrastructure defects and the involved mutated genes are associated to some extent to the clinical profile. The disease, even in nowadays, is not recognized at an early age and the primary care clinician should have knowledge of its clinical spectrum in order to select appropriately the children who need further investigation for the diagnosis of this disorder.
Core tip: The clinical spectrum of primary ciliary dyskinesia (PCD) has been recently better understood through the evolution of electron microscopy techniques, molecular genetics and imaging of the respiratory tract. Herein, we highlight the clinical profile of the disease from infancy to adolescence, focusing on clinical studies of children with a laboratory confirmed diagnosis of PCD. Additionally, the currently recognized associations of the type of ciliary ultrastructure defects and involved mutated genes with the clinical spectrum of the disease are presented. This information is of interest for the paediatrician in order to conduct a timely investigation of children with symptoms suggestive of PCD.